Novo Nordisks GLP1 Trial Falls Short

Novo Nordisk’s GLP‑1 Trial Falls Short

The Promise That Didn’t Deliver Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs like Ozempic and Wegovy, has confirmed that its late‑stage trial of an older oral version of semaglutide failed to meet its main goal. The trial aimed to test whether the drug could slow cognitive decline in patients with Alzheimer’s disease. The…

A Controversial Appointment

A Controversial Appointment

The Announcement The Department of Health and Human Services confirmed that Ralph Abraham, Louisiana’s surgeon general, has been tapped to serve as the CDC’s principal deputy director. This position is second only to the director, a role currently vacant, meaning Abraham will essentially be running the agency. The appointment has already sparked debate. Abraham is…